Nautilus Biotechnology (NAUT) Income from Continuing Operations (2020 - 2021)
Nautilus Biotechnology (NAUT) reported Income from Continuing Operations of 2079993.0 for Q1 2021, down 51.16% sequentially from 1376035.0 in Q4 2020.
Nautilus Biotechnology (NAUT) Income from Continuing Operations (2020 - 2021) Analysis & Trends
Nautilus Biotechnology (NAUT) has 2 years of Income from Continuing Operations data on file, last reported at 2079993.0 in Q1 2021.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Income (Continuing) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -37.09 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 227.36 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -3.68 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 1.03 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 727.20 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | -26.94 Mn |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 362.00 Mn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -453.82 Mn |
| 10 | Nautilus Biotechnology | 224.14 Mn | 224.14 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2021 | -2.08 Mn |
| Dec 31, 2020 | -1.38 Mn |
| Sep 30, 2020 | -586,388.00 |